Wong, C, Dakin, R S, Williamson, J, Newton, J, Steven, M, Colville, S, Stavrou, M, Gregory, J M, Elliott, E, Mehta, A R, Chataway, J, Swingler, R J, Parker, R A, Weir, C J, Stallard, N, Parmar, M K B, Macleod, M R, Pal, S & Chandran, S 2022, ' Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron disease ', BMJ Open, vol. 12, no. 7, pp. e064173 . https://doi.org/10.1136/bmjopen-2022-064173
De Icaza Valenzuela, M M, Bak, T H, Thompson, H E, Colville, S, Pal, S & Abrahams, S 2021, ' Validation of The Edinburgh Cognitive and Behavioural ALS Screen (ECAS) in behavioural variant Frontotemporal Dementia and Alzheimer's Diseas e ', International Journal of Geriatric Psychiatry . https://doi.org/10.1002/gps.5566
Chataway, J, De Angelis, F, Connick, P, Parker, R A, Plantone, D, Doshi, A, John, N, Stutters, J, Macmanus, D, Prados Carrasco, F, Barkhof, F, Ourselin, S, Braisher, M, Ross, M, Cranswick, G, Pavitt, S H, Giovannoni, G, Gandini Wheeler-kingshott, C A, Hawkins, C, Sharrack, B, Bastow, R, Weir, C J & Stallard, N & Chandran, S 2020, ' Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART) : a phase 2b, multiarm, double-blind, randomised placebo-controlled trial ', The Lancet Neurology, vol. 19, no. 3, pp. 214-225 . https://doi.org/10.1016/S1474-4422(19)30485-5 O2, repositorio institucional de la UOC Universitat Oberta de Catalunya (UOC) Chataway, J, De Angelis, F, Connick, P, Parker, R A, Plantone, D, Doshi, A, John, N, Stutters, J, MacManus, D, Prados Carrasco, F, Barkhof, F, Ourselin, S, Braisher, M, Ross, M, Cranswick, G, Pavitt, S H, Giovannoni, G, Gandini Wheeler-Kingshott, C A, Hawkins, C, Sharrack, B, Bastow, R, Weir, C J, Stallard, N, Chandran, S & MS-SMART Investigators 2020, ' Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART) : a phase 2b, multiarm, double-blind, randomised placebo-controlled trial ', The Lancet Neurology, vol. 19, no. 3, pp. 214-225 . https://doi.org/10.1016/S1474-4422(19)30485-5 The Lancet Neurology, 19(3), 214-225. Lancet Publishing Group
Elliott, E, Newton, J, Rewaj, P, Gregory, J M, Tomarelli, L, Colville, S, Chandran, S & Pal, S 2019, ' An epidemiological profile of dysarthria incidence and assistive technology use in the living population of people with MND in Scotland ', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, pp. 1-7 . https://doi.org/10.1080/21678421.2019.1672748
Leighton, D J, Newton, J, Stephenson, L J, Colville, S, Davenport, R, Gorrie, G, Morrison, I, Swingler, R, Chandran, S & Pal, S 2019, ' Changing epidemiology of motor neurone disease in Scotland ', Journal of Neurology . https://doi.org/10.1007/s00415-019-09190-7